FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.0  |  FHIR Version n/a  User: [n/a]

929360081000036101: Medicinal product pack reference set (foundation metadata concept)


Status: current, Primitive. Date: 31-Mar 2011. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
3288201000168119 MPP (medicinal product pack) reference set en Synonym Active Case sensitive Australian Medicines Terminology module
965507131000036117 Medicinal product pack reference set en Synonym Active Case sensitive Australian Medicines Terminology module
965507141000036110 Medicinal product pack reference set (foundation metadata concept) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4351131000168114 <p>Terminology to describe in a health record an abstract concept representing the properties of one or more quantitatively and clinically equivalent Trade Product Packs.</p><p>This reference set supports the accurate and unambiguous electronic communication and exchange of medicines information between clinicians for medication management and the recording of adverse reactions.</p><p><b>Target client: </b>NCTS</p> en Definition Active Case sensitive Australian Medicines Terminology module


15976 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Medicinal product pack reference set Has licence SNOMED CT-AU licence​ true Inferred relationship Some 1740441059
Medicinal product pack reference set Developed by Australian Digital Health Agency true Inferred relationship Some 991480534
Medicinal product pack reference set Is a Simple type reference set true Inferred relationship Some

Members
hydromorphone hydrochloride 4 mg modified release tablet, 100
hydromorphone hydrochloride 4 mg modified release tablet, 14
hydromorphone hydrochloride 4 mg modified release tablet, 20 tablets (medicinal product pack)
hydromorphone hydrochloride 4 mg modified release tablet, 28
hydromorphone hydrochloride 4 mg modified release tablet, 30
hydromorphone hydrochloride 4 mg modified release tablet, 35
hydromorphone hydrochloride 4 mg modified release tablet, 40
hydromorphone hydrochloride 4 mg modified release tablet, 50
hydromorphone hydrochloride 4 mg modified release tablet, 60
hydromorphone hydrochloride 4 mg modified release tablet, 7
hydromorphone hydrochloride 4 mg tablet, 10
hydromorphone hydrochloride 4 mg tablet, 100
hydromorphone hydrochloride 4 mg tablet, 20
hydromorphone hydrochloride 4 mg tablet, 500 tablets (medicinal product pack)
hydromorphone hydrochloride 4 mg tablet, 60
hydromorphone hydrochloride 50 mg/mL injection, 10 x 1 mL ampoules
hydromorphone hydrochloride 50 mg/mL injection, 5 x 1 mL ampoules
hydromorphone hydrochloride 50 mg/5 mL injection, 10 x 5 mL ampoules
hydromorphone hydrochloride 50 mg/5 mL injection, 5 x 5 mL ampoules
hydromorphone hydrochloride 500 mg/50 mL injection, 50 mL vial
hydromorphone hydrochloride 64 mg modified release tablet, 10
hydromorphone hydrochloride 64 mg modified release tablet, 100
hydromorphone hydrochloride 64 mg modified release tablet, 14
hydromorphone hydrochloride 64 mg modified release tablet, 20
hydromorphone hydrochloride 64 mg modified release tablet, 28
hydromorphone hydrochloride 64 mg modified release tablet, 30
hydromorphone hydrochloride 64 mg modified release tablet, 35
hydromorphone hydrochloride 64 mg modified release tablet, 40
hydromorphone hydrochloride 64 mg modified release tablet, 50
hydromorphone hydrochloride 64 mg modified release tablet, 60
hydromorphone hydrochloride 64 mg modified release tablet, 7
hydromorphone hydrochloride 8 mg modified release tablet, 10
hydromorphone hydrochloride 8 mg modified release tablet, 100
hydromorphone hydrochloride 8 mg modified release tablet, 14
hydromorphone hydrochloride 8 mg modified release tablet, 20
hydromorphone hydrochloride 8 mg modified release tablet, 28
hydromorphone hydrochloride 8 mg modified release tablet, 30
hydromorphone hydrochloride 8 mg modified release tablet, 35
hydromorphone hydrochloride 8 mg modified release tablet, 40
hydromorphone hydrochloride 8 mg modified release tablet, 50
hydromorphone hydrochloride 8 mg modified release tablet, 60
hydromorphone hydrochloride 8 mg modified release tablet, 7
hydromorphone hydrochloride 8 mg tablet, 10
hydromorphone hydrochloride 8 mg tablet, 100
hydromorphone hydrochloride 8 mg tablet, 20
hydromorphone hydrochloride 8 mg tablet, 60
hydroquinone 2% + salicylic acid 1.5% + padimate-O 3% cream, 20 mL
hydroquinone 2% + salicylic acid 1.5% + padimate-O 3% cream, 60 mL
hydroxocobalamin 1 mg/mL injection, 2 x 1 mL ampoules
hydroxocobalamin 1 mg/mL injection, 3 x 1 mL ampoules
hydroxycarbamide (hydroxyurea) 500 mg capsule, 100
hydroxycarbamide (hydroxyurea) 500 mg capsule, 30
hydroxychloroquine sulfate 200 mg tablet, 100
hydroxyethyl starch 130/0.4 6% (30 g/500 mL) + sodium chloride 0.6% (3.01 g/500 mL) + sodium acetate trihydrate 2.315 g/500 mL + potassium chloride 150 mg (potassium 2 mmol)/500 mL + magnesium chloride hexahydrate 150 mg/500 mL injection, 15 x 500 mL bags
hydroxyethyl starch 130/0.4 6% (30 g/500 mL) + sodium chloride 0.6% (3.01 g/500 mL) + sodium acetate trihydrate 2.315 g/500 mL + potassium chloride 150 mg (potassium 2 mmol)/500 mL + magnesium chloride hexahydrate 150 mg/500 mL injection, 20 x 500 mL bags
hydroxyethyl starch 130/0.4 6% (60 g/L) + sodium chloride 0.9% (9 g/L) injection, 10 x 500 mL bags
hydroxyethyl starch 130/0.4 6% (60 g/L) + sodium chloride 0.9% (9 g/L) injection, 10 x 500 mL bottles
hydroxyethyl starch 130/0.4 6% (60 g/L) + sodium chloride 0.9% (9 g/L) injection, 15 x 500 mL bags
hydroxyethyl starch 130/0.4 6% (60 g/L) + sodium chloride 0.9% (9 g/L) injection, 20 x 500 mL bags
hylan G-F 20 8 mg/mL injection, 6 mL syringe
hyoscine butylbromide 10 mg suppository, 6
hyoscine butylbromide 10 mg tablet, 10
hyoscine butylbromide 10 mg tablet, 100
hyoscine butylbromide 10 mg tablet, 20
hyoscine butylbromide 20 mg/mL injection, 10 x 1 mL ampoules
hyoscine butylbromide 20 mg/mL injection, 5 x 1 mL ampoules
hyoscine butylbromide 20 mg tablet, 10
hyoscine hydrobromide 150 microgram chewable tablet, 12
hyoscine hydrobromide 300 microgram chewable tablet, 10
hyoscine hydrobromide 300 microgram chewable tablet, 12
hyoscine hydrobromide 300 microgram chewable tablet, 2
hyoscine hydrobromide 300 microgram tablet, 10
hyoscine hydrobromide 300 microgram tablet, 2
hyoscine hydrobromide 400 microgram/mL injection, 5 x 1 mL ampoules
hyoscine hydrobromide 400 microgram/mL injection, 50 x 1 mL ampoules
sodium chloride 0.022% + hypochlorous acid 0.004% + sodium hypochlorite 0.004% irrigation solution, 250 mL
hypromellose 20 mg/mL gel, 100 g
hypromellose 0.3% w/w eye drops, 10 mL
hypromellose 0.3% w/w eye drops, 15 mL
hypromellose 0.3% w/v eye drops, 10 mL
hypromellose 0.5% eye drops, 15 mL
ibandronate 50 mg tablet, 28
ibandronate 50 mg tablet, 7
ibandronate 50 mg tablet, 84
ibandronate 6 mg/6 mL injection, 6 mL vial
ibandronate 6 mg/6 mL injection, 10 x 6 mL vials
ibandronate 6 mg/6 mL injection, 5 x 6 mL vials
ibrutinib 140 mg capsule, 120
ibrutinib 140 mg capsule, 90
ibrutinib 140 mg tablet, 30
ibrutinib 280 mg tablet, 30
ibrutinib 420 mg tablet, 30
ibrutinib 560 mg tablet, 30
ibuprofen 10 mg/2 mL injection, 4 x 2 mL ampoules
ibuprofen 100 mg/5 mL oral liquid, 100 mL
ibuprofen 100 mg/5 mL oral liquid, 150 mL
ibuprofen 100 mg/5 mL oral liquid, 20 mL
ibuprofen 100 mg/5 mL oral liquid, 200 mL
ibuprofen 100 mg/5 mL oral liquid, 25 mL
ibuprofen 100 mg/5 mL oral liquid, 30 mL
ibuprofen 100 mg / 5 mL oral liquid, 45 mL (medicinal product pack)

Start Previous Page 87 of 160 Next End


Reference Sets

Reference set descriptor

Back to Start